Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz. The 4,500 m² centre houses chemical and analytical facilities, laboratories and advanced technologies including flow chemistry, distillation and process analytics, plus office space. There are workspaces for over 100 and 40 new jobs have been created.

French-based CDMO Novasep has announced two sales. Henagen, its Belgium-based viral vectors operation, has been sold to Thermo Fisher Scientific for about €725 million, while, in a much smaller deal, it also intends to sell its chromatography equipment division to Sartorius Stedim Biotech.